Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 10, Issue 1
Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primate
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Clinical/translational cancer immunotherapy
Original research
Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primate
Online download statistics by month:
Online download statistics by month: January 2022 to April 2023
Abstract
Full
Pdf
Jan 2022
774
799
425
Feb 2022
651
671
275
Mar 2022
484
494
150
Apr 2022
535
548
134
May 2022
210
225
109
Jun 2022
221
228
65
Jul 2022
201
206
78
Aug 2022
232
233
67
Sep 2022
223
225
77
Oct 2022
234
242
71
Nov 2022
335
343
120
Dec 2022
205
212
54
Jan 2023
163
166
57
Feb 2023
196
197
63
Mar 2023
170
171
54
Apr 2023
168
177
65
Total
5002
5137
1864
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?